Showing results (131-140 of 547) with videos related to
Sort By:
Pageof 55
Hepatology (Baltimore, Md.)|August 1, 1991
Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed ratsH C Lin, O Soubrane, D LebrecThe American Journal of Medicine|April 6, 1992
Pharmacokinetics of lomefloxacin in patients with cirrhosisD Lebrec, C Gaudin, J P BenhamouDigestive Diseases and Sciences|September 1, 1994
Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatinS Grimbert, D Pessayre, C Degott, et al.Molecular Pharmacology|June 1, 1994
Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodiesM Bourdi, M Tinel, P H Beaune, et al.Revue Medicale De Liege|May 22, 1998
[Pseudo-alcoholic hepatitis and cirrhosis caused by amiodarone (Cordarone)]A Lamproye, J Ramos, D Larrey, et al.Journal of Hepatology|January 1, 1985
Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive ratsP Calès, A Braillon, C Girod, et al.Acta Gastro-Enterologica Belgica|April 10, 2008
Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascitesT Sersté, D Lebrec, D Valla, et al.Liver|July 8, 1999
Down-regulation of vascular alpha1-adrenoceptors does not account for the loss of vascular responsiveness to catecholamines in experimental cholestasisK Dabagh, O Said, D Lebrec, et al.Alimentary Pharmacology & Therapeutics|November 14, 1997
Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive ratsR Moreau, S Cailmail, D Valla, et al.Journal of Hepatology|January 1, 1993
Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosisA Braillon, S Cailmail, C Gaudin, et al.Pageof 55